tVNS, especially concha targeting, linked to better sleep quality and lower insomnia severityVagus Nerve Stimulation Shows Potential to Improve Sleep Quality
Sleep medicine reviewsPublished October 5, 2026Study authors: Choi Beom Jin, Choi Hyuk, Kang NyeonjuPubMed ↗DOI ↗Editorial oversight: Dr. Ji-eun Park, MD · Brain, Mind & Pain
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Consider tVNS as a preliminary option for insomnia; effect sizes and safety data are lacking.
This meta-analysis of randomized controlled trials evaluated transcutaneous vagus nerve stimulation (tVNS) in participants with impaired sleep quality, timing, or duration. The authors synthesized evidence on sleep quality, measured by the Pittsburgh Sleep Quality Index, and insomnia severity, measured by the Athens Insomnia Scale and Insomnia Severity Index.
tVNS protocols were associated with better sleep quality and lower insomnia severity. Stimulation targeting the concha region was associated with better sleep quality, and better sleep quality was associated with lower ages of participants, suggesting age may moderate the response.
The abstract does not report effect sizes, absolute numbers, p-values, or confidence intervals, so the magnitude of these associations is unclear. Safety outcomes, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported. Limitations, funding, and conflicts of interest were also not reported. The authors describe results as "influenced" and "associated with," and the certainty of evidence is not reported.
These findings suggest tVNS, particularly concha-targeted protocols, may be associated with favorable changes in sleep quality and insomnia severity, but the lack of quantitative effect estimates and safety data limits clinical conclusions. Age may moderate response, but this requires further characterization.
How this fits prior evidence
Prior coverage has highlighted other nonpharmacologic and pharmacologic options for insomnia, including integrated Traditional Chinese Medicine plus Western medicine, adjunctive acupoint application in post-stroke sleep disorders, and dual orexin receptor antagonists (DORAs), which show the strongest evidence for insomnia. This meta-analysis extends that landscape by examining tVNS, a neuromodulation approach, and suggests associations with better sleep quality and lower insomnia severity, particularly with concha targeting. However, unlike prior network meta-analyses that ranked interventions, this analysis does not provide comparative effect sizes or safety data, so its findings remain preliminary and do not establish tVNS as superior or equivalent to existing options.
Researchers looked at how transcutaneous vagus nerve stimulation (tVNS) affects people with poor sleep quality, timing, or duration. This type of treatment involves using a device to stimulate a specific nerve in the body. The study looked at several outcomes, including overall sleep quality and the severity of insomnia symptoms.
The results showed that tVNS protocols were linked to better sleep quality and lower insomnia severity. Specifically, when the stimulation targeted the concha region, it was associated with improved sleep. The study also noted that younger participants tended to show better sleep quality results.
Because this is a meta-analysis of several trials, the findings are promising but should be viewed with caution. The study did not provide specific numbers for how much the sleep improved or report any specific side effects. Talk to your doctor to see if this type of treatment is right for your specific needs.
What this means for you:
Vagus nerve stimulation may improve sleep quality and reduce insomnia severity, especially when targeting the concha.
Common questions
What is transcutaneous vagus nerve stimulation?
Transcutaneous vagus nerve stimulation, or tVNS, is a method of stimulating the vagus nerve through the skin. In this study, tVNS was found to influence better sleep quality and lower insomnia severity. Specifically, targeting the concha region was linked to improved sleep quality.
Does this treatment work for everyone with insomnia?
The study found that tVNS protocols influenced better sleep quality and lower insomnia severity. However, the results showed that better sleep quality was associated with lower ages of participants, suggesting that age may influence how well the treatment works for different people.
Are there any known side effects to this treatment?
The provided data did not report any specific adverse events, serious side effects, or issues with how well the treatment was tolerated. You should consult with a healthcare professional to discuss the safety and suitability of this treatment for your specific health situation.
Impairments in sleep quality, timing, or duration disrupt normal sleep patterns. This systematic review and meta-analysis investigated the effects of transcutaneous vagus nerve stimulation (tVNS) protocols on sleep outcomes. Thirteen randomized controlled trials with parallel or crossover designs that applied tVNS intervention and assessed sleep quality (Pittsburgh Sleep Quality Index) and insomnia severity (Athens Insomnia Scale and Insomnia Severity Index) were included. Effect sizes were calculated by comparing changes between the active tVNS and control groups. Moderator analyses examined whether stimulation of different targeted regions influences sleep outcomes. Meta-regression analyses examined potential relationships between the effects of tVNS protocols on sleep quality and demographic characteristics and multiple tVNS parameters, respectively. The random-effects meta-analysis indicated that tVNS protocols influenced better sleep quality and lower insomnia severity. Moderator variable analysis revealed that tVNS targeting the concha region induced better sleep quality. Meta-regression analysis revealed that better sleep quality was associated with lower ages of participants. These findings suggest that tVNS protocols, particularly those targeting the concha, were associated with favorable changes in sleep quality and insomnia severity, with age potentially moderating the treatment response.
